Session Details
[2MLS25]Accelerating Drug Discovery with Gene Synthesis, Protein Expression, and Purification Services
Wed. Dec 2, 2026 12:55 PM - 1:45 PM JST
Wed. Dec 2, 2026 3:55 AM - 4:45 AM UTC
Wed. Dec 2, 2026 3:55 AM - 4:45 AM UTC
Room 25 (Exhibition Hall Open Stage)
Chairperson: Maeda Shintaro (FEI Company Japan)
Thermo Fisher Scientific
In drug discovery research, the rapid and reliable preparation of high-quality target proteins is essential for downstream functional and structural studies. In this seminar, we will introduce our comprehensive contract service covering the entire workflow from synthetic gene design and synthesis, including sequence optimization, to protein expression and purification using the Gibco™ Expi Expression System portfolio.
We will also present a case study in which a target protein expressed and purified through this service was successfully analyzed at atomic resolution using the Thermo Scientific™ Glacios™ 2 Cryo-TEM. Through this example, we will demonstrate an integrated workflow combining high-quality protein sample preparation with cryo-electron microscopy (cryo-EM) single-particle analysis and discuss its potential to advance structure-based drug design (SBDD) in drug discovery research.
We will also present a case study in which a target protein expressed and purified through this service was successfully analyzed at atomic resolution using the Thermo Scientific™ Glacios™ 2 Cryo-TEM. Through this example, we will demonstrate an integrated workflow combining high-quality protein sample preparation with cryo-electron microscopy (cryo-EM) single-particle analysis and discuss its potential to advance structure-based drug design (SBDD) in drug discovery research.
[2MLS25-01]Accelerating Drug Discovery with Gene Synthesis, Protein Expression, and Purification Services
Yuichiro Kezuka (Life Technologies Japan Ltd.)
[2MLS25-02]Accelerating Drug Discovery with Gene Synthesis, Protein Expression, and Purification Services
Shintaro Maeda (FEI Company Japan)
